One-Liner
A valuation and negotiation support service for rare-disease patient advocacy foundations to model voucher-sale terms, timing, and leverage when selling FDA Rare Pediatric Disease Priority Review Vouchers to big-pharma acquirers.
AI Thinking Process
FDA Rare Pediatric Disease Priority Review Voucher program reauthorized Dec 2024 for approvals through Sept 2026. Vouchers trade at $80-150M. Rare-disease foundations sometimes influence voucher transactions. Valuation service for foundations.
Idea history contains 'FDA National Priority Voucher Allocation Predictor for Pharma BD Teams' — same underlying data, different customer. Also 'AI-Discovered Drug Phase III Readout Calendar' — adjacent shape.
G144 non-commercial buyer: foundations don't buy SaaS at $10K-100K/year. Voucher transactions are episodic — consulting economics, not SaaS.
Pivot to law-firm buyers advising foundations — Wilson Sonsini, Wiggin & Dana. Would pay $30-60K/year. Only 3-8 such firms exist. $180K-480K ARR total. Sub-scale.
Killed by G144 non-commercial buyer (foundations) + sub-scale addressable pivot market (3-8 law firms at $180K-480K ARR total).
Kill Reason
G144 non-commercial buyer: rare-disease patient advocacy foundations are structurally non-commercial buyers — they do not purchase SaaS at $10,000-100,000/year. Voucher transactions are episodic (once per foundation per decade), making consulting-project economics correct and SaaS economics wrong. Pivot to law-firm buyers (Wilson Sonsini, Wiggin & Dana rare-disease practices) produces an addressable market of only 3-8 law firms at $60,000/year = $180,000-480,000 ARR total. Sub-scale.
Risk Analysis
Risk analysis available for latest engine ideas.
Loading...
Related ideas you can explore free:
killed: Open-source middleware (HAMi) already provides heterogeneous AI computing virtualization for free. Proprietary play is squeezed between free open-source and vertically integrated hardware vendor ecosystem.
killed: 5+ funded competitors including Cast AI ($1B valuation), OneChronos (backed by Nobel laureate), Akash Network (decentralized, 80% cheaper), Argentum AI (blockchain-settled). Market is claimed with massive capital.
killed: Template epidemic (G003) + industry-pain-form death pattern (G005) fire simultaneously. 13+ existing compliance tools. A prompt could do 80% of this.